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Meta-analysisBackground:With tobacco smoking, diet is the main source of cadmium (Cd) exposure in the general population.
The carcinogenic and estrogenic activities of Cd make it a contaminant of potential concern for hormone-
dependent cancers including breast cancer. Postmenopausal women represent the most appropriate population
to investigate the possible impact of exogenous factors with potential estrogenic activity on breast cancer as, after
menopause, their estrogenic inﬂuence is predominant.
Objectives:We systematically reviewed available studies on the association between dietary exposure to Cd and
breast cancer focusing on postmenopausal women. A meta-analysis combining the risk estimators was performed
and potential sources of between studies heterogeneity were traced.
Methods: Studies were searched from MEDLINE through 31 January 2015 and from the reference lists of relevant
publications. Six eligible studies published between 2012 and 2014 were identiﬁed and relative risk estimates
were extracted. Meta-rate ratio estimates (mRR) were calculated according to ﬁxed and random-effect models.
Meta-analyses were performed on the whole set of data and separate analyses were conducted after stratiﬁcation
for study design, geographic location, use of hormone replacement therapy (HRT), tumor estrogen receptor status
(ER+ or ER−), progesterone receptor status (PGR+ or PGR−), body mass index (BMI), smoker status, zinc or
iron intake.
Results: No statistically signiﬁcant increased risk of breast cancer was observed when all studies were combined
(mRR = 1.03; 95% conﬁdence interval [CI]: 0.89–1.19). Several sources of heterogeneity and inconsistency were
identiﬁed, including smoker status, HRT use, BMI, zinc and iron intake. Inconsistency was also strongly reduced
when only considering ER−, PGR−, tumors subgroups fromUSA and from Japan. The riskswere, however, not sub-
stantially modiﬁed after stratiﬁcations. No evidence of publication bias was found.
Conclusion: The present study does not provide support for the hypothesis that dietary exposure to Cd increases the
risk of breast cancer in postmenopausal women.Misclassiﬁcation in dietary Cd assessment in primary studies could
have biased the results towards a ﬁnding of no association.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
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Cadmium is awidespreadmetallic element occurring in the environ-
ment naturally (e.g., volcanic activity, weathering of Cd-containing
rocks, and sea spray), and as a pollutant emanating from industrial
(e.g., batteries, coatings, and plastic stabilizers), agricultural
(e.g., contamination of phosphate fertilizers), and other sources
(e.g., release from motor vehicle fuel combustion and tire wear)
(Agency for Toxic Substances and Disease Registry, 2011; CCC, 2014).
Environmental pollution and particularly soil contamination by Cd rep-
resents a health problem because grains, leafy and root vegetables
bioconcentrate Cd, resulting in signiﬁcant sources of Cd exposure for
the general population through diet and tobacco smoking (Satarug
and Moore, 2004; Järup and Akesson, 2009). However, recent data on
Cd concentrations in crops and food argue in favor of a decreasing
trend and the recently revised input/output scenarios for EU agricultur-
al soils conclude that the current net balance of Cd in EU soils is negative
(Six and Smolders, 2014).
Cadmium concentrations in food vary considerably, but, generally,
ﬁber rich foods like cereals, vegetables and shellﬁsh are the major con-
tributors to Cd intake in humans. Inmany countries, rice is the dominat-
ing source of exposure and signiﬁcantly contributes to Cd exposure
(Vahter et al., 2007). The average Cd intake from food varies interna-
tionally from 8 to 25 μg/day and daily Cd exposure can double in
smokers (Sartor et al., 1992). Approximately 5% of Cd ingested in food
is absorbed, depending on the nutritional status (Godt et al., 2006).
Only a small fraction of inhaled or ingested Cd is excreted, resulting in
increasing body burden over time (Klaassen, 1981). Cd is taken up by
transport mechanisms developed for essential metals, most likely zinc
(Zn2+), iron (Fe2+), manganese (Mn2+), and calcium (Ca2+) (Satarug
et al., 2010). Cadmium absorption is potentiated by a low iron store sta-
tus (Akesson et al., 2002; Berglund et al., 1994).
Ubiquitous exposure to low levels of Cd has raised concerns about
adverse health effects. Cadmium has been classiﬁed as a group 1
human carcinogen with sufﬁcient evidence for the lung and limited ev-
idence for prostate and kidney (IARC, 2012). Themolecularmechanisms
involved in the carcinogenic activity of Cd are poorly understood. Possi-
ble general and tissue speciﬁc molecular mechanisms as well as epige-
netic modiﬁcations that follow chronic exposure to Cd in breast,
prostate and lung cancers have been recently reviewed by Luevano
and Damodaran (2014). Several mechanisms of Cd carcinogenesis
have been proposed but the most important appears to be oxidative
stress (Joseph, 2009) because of its involvement into aberrant gene ex-
pression, DNA damage, altered DNA damage repair (Jin et al., 2003), and
enhanced proliferation and/or depressed apoptosis (Waalkes, 2003;
Joseph, 2009; Templeton and Liu, 2010). As mitochondria are known
as intracellular targets for Cd and are central to the formation of excess
reactive oxygen species, their implication is highly possible (Luevano
and Damodaran, 2014). In addition, as reported by Julin et al. (2012),
both in vivo and in vitro studies provide evidence that Cd may act as a
metalloestrogen (Johnson et al., 2003; Safe, 2003; Brama et al., 2007;Zang et al., 2009; Garcia-Morales et al., 1994; Ali et al., 2010). Cadmium
was discovered to exert estrogenic activities, such as stimulation of the
proliferation of breast cancer cells (Brama et al., 2007; Martinez-Campa
et al., 2006), activation and increased expression of estrogen regulated
genes (Garcia-Morales et al., 1994; Liu et al., 2008) and activation of
the estrogen receptor (ER)-alpha (Garcia-Morales et al., 1994;
Martinez-Campa et al., 2006; Stoica et al., 2000; Wilson et al., 2004)
supporting the hypothesis that this metal can potentially induce the de-
velopment of hormone-dependent tumors in humans, including breast,
uterus and prostate cancers (Akesson et al., 2008; Benbrahim-Tallaa
et al., 2009; Bertin and Averbeck, 2006). Cd has been shown to up-
regulate progesterone receptor (PGR) levels in breast cancer cells, this
induction being blocked by anti-estrogen (Garcia-Morales et al.,
1994). The combination of carcinogenic and estrogenic activities
makes Cd a contaminant of high concern for hormone-dependent
cancers.
Breast cancer is the most frequently diagnosed cancer and the lead-
ing cause of cancer death amongwomenworldwide (Jemal et al., 2011).
Risk factors for this cancer include elements related to reproductive life
and cumulative exposure to estrogens, e.g., early age at menarche,
nulliparity, late age at ﬁrst pregnancy, short lactation, late menopause,
use of hormone replacement therapy (HRT), high BMI, low physical ac-
tivity and family history (inheritance) of breast cancer. Associations
were also reported with high alcohol consumption, radiation exposure,
high socioeconomic status and higher educational levels (Scottenfeld
and Fraumeni, 2006; Strumylaite et al., 2010).
Several epidemiological studies investigating the association be-
tween dietary Cd exposure and hormone-related cancers have reported
conﬂicting results. A ﬁrst meta-analysis (MA) (Cho et al., 2013) showed
a statistically signiﬁcant positive association between dietary Cd intake
and breast cancer inwomen. In a re-evaluation including two additional
cohort studies, the positive association was no more statistically signif-
icant (Wu et al., 2015). Detecting the activity of estrogenic chemicals in
epidemiological studies is, however, not trivial because of the contribu-
tion of endogenous estrogens. After menopause, exogenous estrogens
are predominant and contribute to breast cancer risk (Strumylaite
et al., 2010). The potential estrogenic inﬂuence of Cd should, therefore,
be better detected in postmenopausal women.
The aim of our study is to re-assess the association between dietary
Cd intake and the risk of breast cancer, by combining the data on post-
menopausal women in a MA. In addition, as heterogeneity has been re-
ported in the previousMA,we conducted sub-group analyses to identify
possible source(s) of heterogeneity.
2. Materials and methods
2.1. Study identiﬁcation and selection
2.1.1. Study identiﬁcation
A search on MEDLINE (National Library of Medicine, Bethesda, MD)
was conducted using the PubMed interface to identify publications
Fig. 1. Flow chart of study selection. Note: n = number of publications.
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search using “(“cadmium”[MeSH Terms] OR “cadmium”[All Fields])
AND (“diet”[MeSH Terms] OR “diet”[All Fields] OR “dietary”[All Fields])
AND (“neoplasms”[MeSH Terms] OR “neoplasms”[All Fields] OR
“cancer”[All Fields])” was initially undertaken. This was supplemented
with the reference lists of the relevant publications in an effort to iden-
tify all available literature that may not have been traced by our data-
base searches. The search was limited to studies published in peer-
reviewed journals as they are likely to be more reliable than unpub-
lished reports.
2.1.2. Study selection
A studywas considered eligible for further review if (i) it referred to
dietary Cd exposure, (ii) if the outcome included breast cancer among
postmenopausal women and (iii) if the study used a cohort or a case–
control design. We excluded studies published in a non-English lan-
guage, those that did not report original results (reviews, meta-
analysis, case-reports, comments, letters, editorials, abstract), non-
human studies, mechanistic studies as well as studies focusing on ge-
netic data. Studies dealing with breast tumor cases among pre- and
postmenopausal women combined with no separate reporting of post-
menopausal women data were not selected, as well as those including
subjects already included in another more complete or more recent
publication examining a greater number of subjects or with longer
follow-up duration.
The systematic review and identiﬁcation of eligible publications was
performed by 1 reviewer (GVMF).
2.2. Data extraction
A structured abstractwas derived from each selected publication, in-
cluding information on the study design and characteristics, location,exposure assessment and disease deﬁnition. Two authors (GVMF and
NL) read the reports and independently extracted and tabulated the
most relevant risk estimators, with their 95% CIs. The results of this ex-
ercise were compared between the authors and consensus was obtain-
ed before the meta-analysis.
2.3. Data analysis
The data analysis is the same as previously described in details in
Van Maele-Fabry et al. (2010, 2012, 2013).
2.3.1. Evaluation of homogeneity
The signiﬁcance of the between-study variance was evaluated with
the ln(RR) or Q statistic test which has a χ2 distribution with degrees
of freedom equal to the number of studies pooled minus 1. The applied
formula is: χ2 = Σwi[ln(RR)i− ln(RR)p]2, for i = 1 to N, where N is the
number of studies combined, RRp is the overall pooled RR estimate, RRi
is the RR for the ith study andwi= 1 / Vi where Vi is the variance of the
ln(RR)i. A low P value for this statistic indicates the presence of hetero-
geneity, which questions the validity of the pooled estimates (Clarke
and Oxman, 2000; Lipsett and Campleman, 1999). When meta-
analyses include small numbers of studies, the power of the test is low
(Hardy and Thompson, 1998). An alternative approach to quantify the
effect of heterogeneity, providing a measure of the degree of inconsis-
tency in the results has been developed by Higgins et al. (2003). The
quantity called I2 describes the percentage of total variation across stud-
ies that is due to heterogeneity rather than chance. I2 can be calculated
as I2= 100% × (Q− df) / Qwhere Q is Cochran's heterogeneity statistic
and df the degree of freedom. Negative values of I2 are put equal to zero
so that I2 lies between 0 and 100%. A value of 0% indicates no observed
heterogeneity and larger values show increasing heterogeneity.
Table 1
Selected characteristics of the studies dealing with dietary cadmium exposure and risk of postmenopausal breast cancer.
Reference
Geographic location
Type of study
Cohort description (study period) Exposure assessment
A. Source of exposure data
B. Exposure category
Disease deﬁnition (case ﬁnding and case
diagnosis)
Adams et al., 2012
USA (13-county area; western
Washington State)
VITamins And Lifestyle (VITAL) pro-
spective cohort
– Participants: female members of the
VITAL cohort aged 50–76 and living in
the 13-county area in western
Washington State covered by the
SEER cancer registry.
– Excluded women: with unknown
breast cancer history or with a previ-
ous breast cancer history; women di-
agnosed after enrolment with rare
breast cancer histologies (sarcoma,
lymphoma, or phyllodes) and from
death certiﬁcate only; because miss-
ing FFQ responses; because reporting
b600 kcal or N4000 kcal daily intake;
pre- and perimenopausal women and
women with unknown menopausal
status.
– Enrolment: 2000–2002, analytic co-
hort = 30,543 postmenopausal
women including 26,801with com-
plete information on all covariates in
the fully adjusted risk model.
– FU: 200–2002 through December 31,
2009. Mean FU time of 7.5 years.
– Incident breast cancer cases: 1026; of
these, 899 had complete covariate in-
formation for adjusted analyses; ER
status available for 880 cases (757
ER+, 123 ER−).
– Mean estimated cadmium intake (SD)
= 10.9 (4.9) μg/day; range: 0.5–55.7
μg/day.
A. Self-administered questionnaire
(24-page) concerning diet, supplement
use, lifestyle, demographics and health
history.
Assessment of dietary intake: food
frequency questionnaire (FFQ), 120 food,
food group and beverage items over the
past one year (adjustment questions on
types of foods and preparation
techniques); FFQ analytic program
calculates average annual servings of each
FFQ food item adjusted to sex-speciﬁc
portion sizes, and estimated nutrient
intakes based on the Minnesota Nutrient
Data System.
Dietary cadmium intake estimated by
combining FFQ responses with US Food
and Drug Administration (US FDA) data
on food cadmium content. Each of the 343
food and beverage line items on the VITAL
FFQ was matched to one or more foods
analyzed by US FDA and on food mapping
created by the US FDA, for FFQ foods for
which no closely similar food was
analyzed by US FDA.
Cadmium concentration for each food =
arithmetic mean of cadmium content
(mg/kg prepared weight) reported by US
FDA for all sample of each food,
1991–2008.
B. Quartile of dietary intake.
– Incidence of breast cancer was
ascertained through linkage of the
cohort to the western Washington
Surveillance, Epidemiology, and End
Results (SEER) cancer registry
through December 31, 2009.
– Information on ER (estrogen recep-
tor) status in breast cancer tissue of
breast cancer patients was retrieved
from SEER.
Adams et al., 2014
US (40 clinical centers)
Women's Health Initiative (WHI)
Prospective study comprising
observational study and randomized
clinical trial
– Participants: postmenopausal women
aged 50–79 years from the WHI study
comprising randomized clinical trial
and observational study.
– Excluded women: with incomplete or
invalid (total energy b600 or N5000
kcal/day) FFQ data or without
follow-up information for cancer di-
agnosis; with a previous breast cancer
history; (women with missing infor-
mation on a given variable were in-
cluded as a separate category for
adjustment).
– Enrolment: 1993–1998; 161,808
women enrolled; 150,889 women in-
cluded in the breast cancer analyses.
– FU: 1993–1998 through August 2009.
Mean FU time of 10.5 years.
– Incident breast cancer cases: 6658; ER
status available for 6109 cases (5161
ER+, 948 ER−).
– Mean estimated cadmium intake
(median) = 10.9 (10.3) μg/day;
range: 0.02–59.4 μg/day.
A. Self-administered questionnaire
concerning dietary habits, lifestyle
(tobacco use, alcohol use, dietary
supplement use, physical activity),
demographic characteristics, reproductive
history (use of postmenopausal
hormones) and medical history;
anthropometric measurements taken at
baseline clinic visits and BMI calculated.
Assessment of dietary intake during the
prior 3 months: food frequency
questionnaire (FFQ), 122 food and
beverage items comprising 302 individual
food and beverage components.
Dietary cadmium intake estimated by
combining FFQ responses with US Food
and Drug Administration data on food
cadmium content. Each of the 302 food
and beverage line items on the WHI FFQ
was matched to one of the foods analyzed
by US FDA and on food mapping created
by the US FDA, for FFQ foods for which no
closely similar food was analyzed by US
FDA (to allow inclusion of participants at
the Hawaii center, 27 additional
component foods speciﬁc to the Hawaii
FFQ were matched).
Urinary cadmium and creatinine:
cadmium concentration was measured in
a subset (n = 1050) of urine samples;
urine creatinine was also measured.
B. Quintile of dietary intake (quartiles for
some adjustments).
– Participants reported incident inva-
sive breast, endometrial or ovarian
cancer and WHI centrally adjudicated
all cases through August 2009; physi-
cian review of medical records.
– Information on ER (estrogen recep-
tor) status in breast cancer tissue of
breast cancer patients [ER+, N =
5161; ER−, N = 948].
Eriksen et al., 2014
Denmark
Diet, Cancer and Health cohort (DCH)
Prospective cohort study
– Participants: 57,053 individuals in-
cluding 29,875 women aged 50–60
years, born in Denmark.
– Excluded women: with a previous
cancer diagnosis.
– Enrolment: 1993–1997, restricted to
postmenopausal at baseline with
complete covariate information,
A. Self-administered, interviewer-checked
192 item semi-quantitative food
frequency questionnaire (FFQ), over the
past 12 months, covering also lifestyle
habits (including present and previous
smoking status), physical activity,
reproductive history, health status and
social factors.
– Danish Cancer Registry used to iden-
tify incident cases of cancer; informa-
tion on ER status, PGR status and
histology type was obtained from The
Danish Breast Cancer Cooperative
Group.
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Table 1 (continued)
Reference
Geographic location
Type of study
Cohort description (study period) Exposure assessment
A. Source of exposure data
B. Exposure category
Disease deﬁnition (case ﬁnding and case
diagnosis)
analytic cohort = 23,815 postmeno-
pausal women.
– FU: 1987–90 through December 31,
2010. Mean FU time of 13 years.
– Incident breast cancer cases: 1390; ER
status available for 1209 cases (981
ER+, 228 ER−); PGR status available
for 671 cases (405 PGR+, 266
PGR−).
– Mean dietary cadmium intake: 14
μg/day (5–95% percentiles = 8–22 μg
cadmium/day).
Assessment of dietary intake: food
monitoring data from the Danish Food
Monitoring Programme for Nutrients and
Contaminants (monitoring cycles running
for 5-year periods), 1993–97 was used for
the calculations.
Dietary cadmium intake per day was
obtained, for each participant in the DCH
cohort, by adding the obtained cadmium
concentration for each food item to the
food table using the FoodCalc program.
B. Tertile of dietary intake.
Itoh et al., 2014
Japan (Nagano Prefecture, 4 hospitals)
Hospital-based case–control study
– Participants: Japanese women aged
20–74 years (405 matched pairs)
from May 2001 to September 2005 at
four hospitals.
– Excluded women: pairs of women
with extremely low or high daily total
energy intake (b500 kcal or ≥4000
kcal) were excluded.
– Enrolment: 390 pairs used in the
analyses including a total of 465 post-
menopausal women (212 cases; 253
controls).
– Postmenopausal women: incident
breast cancer cases: 212; ER status
available for 210 cases (156 ER+, 54
ER−); PGR status available for 210
cases (107 PGR+, 103 PGR−).
– Mean estimated energy-adjusted cad-
mium intake in control subjects =
26.4 μg/day.
A. Self-administered questionnaire
concerning demographic characteristics,
anthropometric factors, smoking habits,
family history of cancer, physical activity,
medical history, menstrual and
reproductive history.
Assessment of dietary intake: 136-item
semi-quantitative FFQ (evaluating
average food intake over the last year); 10
frequency categories and relative sizes
compared to standard portions (3
amounts: small, medium, large). Data
used to calculate consumption for each
food groups (g/day), nutrients (mg/day)
and cadmium (μg/day).
Cadmium content of food obtained from
JECFA and the Committee on
Pharmaceutical and Food Sanitation of the
Ministry of Health, Labor and Welfare of
Japan. 6 food groups selected: rice, wheat,
soybeans, stem/root vegetables, leafy
vegetables, other vegetables or fruits.
Daily cadmium intake estimated by mul-
tiplying frequency of consumption by
portion size and the average cadmium
content in each food item.
B. Tertile of dietary intake.
– Cases = women with newly arising,
histologically conﬁrmed invasive
breast cancer admitted to any of the 4
hospitals during the survey period;
controls = healthy subjects selected
from among medical checkup exam-
inees in 2 of the hospitals, who were
conﬁrmed to not have cancer; 1 con-
trol matched to 1 case by age (within
3 years) and residential area during
the study period.
– Information on ER (estrogen recep-
tor) and PR (progesterone receptor)
status in breast cancer tissue of breast
cancer patients was obtained from
medical records.
Julin et al., 2012
Sweden central counties : Västmanland
and Uppsala
Swedish Mammography
CohortProspective cohort study
– Participants were women born be-
tween 1914 and 1948 invited to a
mammography screening (n =
90,303); cohort established in 1987 to
1990.
– Excluded women: with incorrect or
missing national registration number,
reporting implausible values for ener-
gy intake, with a previous cancer
diagnosis, with diabetes.
– Enrolment: 30,825 participants who
were postmenopausal at baseline
(1987–1990) + 27,705 who self--
reported cessation of menstruation
during follow-up + women classiﬁed
as postmenopausal if they had had
bilateral oophorectomy or were 55
year old or older.
– Analytic cohort for the primary anal-
ysis = 55,987 postmenopausal
women.
– FU: 1987–1990 in Uppsala and Janu-
ary 1998 in Västmanland through De-
cember 31, 2008. Average of 12.2
years (712,075 person-years).
– Incident breast cancer cases: 2112; ER
status available for 1916 cases (1,626
ER+, 290 ER−).
– Mean estimated energy-adjusted cad-
mium intake in the cohort = 15
μg/day ± 3.2 (SD).
A. Self-administered questionnaire
concerning diet, lifestyle and reproductive
factors; response rate being 74%.
Uppsala (54% of the cohort): additional
questionnaire including information on
history of oral contraceptive use,
postmenopausal hormone use, age at
menarche and menopause.
In 1997: second questionnaire sent to gain
information on smoking status and details
on reproductive factors; response rate
being 70%.
Assessment of dietary intake: 67-item
food frequency questionnaire (FFQ);
frequency of each item reported using 8
predeﬁned categories (from never/seldom
to 4 times a day).
Average daily exposure to dietary
cadmium estimated by multiplying the
frequency of consumption by the
age-speciﬁc portion sizes and the average
cadmium content in each food item.
Cadmium content of food obtained from
the National Food Administration and
from Finnish and Danish data (for pepper,
spinach, leek and citrus fruits). Exposure
from air contributes to less than 1% and
community-provided tap water and water
from private wells contribute on average
with 0.2% of the total cadmium exposure.
Cross classiﬁcation of FFQ-estimated
dietary cadmium and urinary cadmium
concentration (reﬂecting the long-term
kidney accumulation of the metal)
– Histology conﬁrmed cases identiﬁed
by linkage of the cohort to the Na-
tional Cancer Registry.
– ER status obtained from pathology
logs at the Uppsala University Hospi-
tal (1987–1994) and from the Quality
Registry at the Regional Oncology
Centre (1994–2008).
– Dates of death were ascertained by
linkage to the Swedish Death
Registry.
(continued on next page)
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Table 1 (continued)
Reference
Geographic location
Type of study
Cohort description (study period) Exposure assessment
A. Source of exposure data
B. Exposure category
Disease deﬁnition (case ﬁnding and case
diagnosis)
resulted in 51% sensitivity and 58%
speciﬁcity.
B. Tertile of dietary intake (estimated
daily cadmium intake adjusted for total
energy intake of 1700 kcal [mean of the
cohort]).
Sawada et al., 2012
Japan The Japan Public Health Center--
based Prospective study (2 cohorts):
cohort I (Iwate, Akita, Nagano, Okinawa,
Tokyo excluded in this study), cohort II
(Ibaraki, Niigata, Kochi, Nagasaki,
Okinawa, Osaka)
Population-based prospective study
– Participants were men and women
45–74 years of age (n = 98,519
[46,033 men + 52,486 women])
drawn from Japan Public Health Cen-
ters.
– Excluded subjects: those with a histo-
ry of cancer, those who reported ex-
treme total energy intake (b990
kcal/day or ≥4204 kcal/day in men
and b843 kcal/day or ≥3686 kcal/day
in women); all subjects in Tokyo be-
cause incidence data were not avail-
able;
– Analytic cohort for the primary anal-
ysis = 90,383 subjects including 5849
with cancer.
– Enrolment: Prospective study con-
ducted in 2 cohorts initiated in 1990
(cohort I; 5-year FU: 1995) and 1993
(cohort II; 5-year FU: 1998).
– FU: until 31 December 2006 (average
FU period: 9-year).
– Newly diagnosed cases of cancer: N =
5849 (3586 men, 2263 women in-
cluding 402 breast cancers [18%]).
– Average estimated energy-adjusted
cadmium intake in the cohort = 26.5
μg/day.
A. Self-administered questionnaire (FFQ)
at baseline and after a 5-year FU with
more comprehensive information on
food-intake frequency than the ﬁrst one
(5-year FU used as baseline to assess
dietary exposure). Questionnaire included
information on medical history and
lifestyle factors (smoking, alcohol
consumption).
Assessment of dietary intake: 138 food
and beverage FFQ items with standard
portions/units (speciﬁed for each food
items in 3 amounts: small, medium, large)
and 9 frequency categories.
Assessment of cadmium dietary intake:
from 6 food groups (rice, wheat, soybeans,
stem/root vegetables, leafy vegetables,
other vegetables or fruits), based on the
questionnaire data.
Cadmium intake calculated by multiplying
the average cadmium concentration in
each item (based on reports from the Join
FAO/WHO Expert Committee on Food
Additives and the Committee on
Pharmaceutical and Food Sanitation of the
Ministry of Health, Labor and Welfare of
Japan) by the quantity of each item. Expo-
sure from air contributes to less than 1%
and cadmium in drinking water is limited
to less than 0.01 mg/L→ cadmium intake
via water and air were ignored.
B. Tertile of cadmium intake for breast
cancer, with the lowest consumption cat-
egory as the reference. Estimated daily
cadmium intake was adjusted for total
energy intake.
– Incident cancers were identiﬁed by
reports from hospitals (64%), regis-
tries (26%), death certiﬁcates (10%)
and responses to questionnaires and
others (0.2%).
– Cases were coded using the Interna-
tional Classiﬁcation of Diseases for
Oncology, third edition (ICD-O-3).
Abbreviations: FAO/WHO, Food and Agriculture Organization/World Health Organization; FFQ, food frequency questionnaire; FU, follow-up; ICD-O-3, the International Classiﬁcation of
Diseases for Oncology, third edition; JECFA, the Joint FAO/WHO Expert Committee on Food Additives; SEER, Surveillance, Epidemiology, and End Results (cancer registry); US FDA,
United States Food and Drug Administration; VITAL, VITamins And Lifestyle; and WHI, Women's Health Initiative.
Table 2
Estimated cadmium dietary intakes in the studies included in the meta-analysis and in the respective general populations.
Reference Geographic location Mean Cd intake in the cohort (μg/day) Mean Cd intake in the general population (μg/day)
Adams et al., 2012 USA 10.9 (SD: 4.9)
Range: 0.5–55.7
9.39a
Adams et al., 2014 USA 10.9
Median: 10.3
Range: 0.02–59.4
9.39a
Eriksen et al., 2014 Denmark 14
5–95% percentiles: 8–22
16 (1993–1997)b
10 (1998–2003)c
10.8 (2004–2011)c
Julin et al., 2012 Sweden Energy-adjusted: 15 ± 3.2 ~15d
Itoh et al., 2014 Japan Energy-adjusted in controls: 26.4⁎ 25.5e
Sawada et al., 2012 Japan Energy-adjusted: 26.5⁎⁎ 25.5e
25.9f
⁎ Women pre-and postmenopausal.
⁎⁎ The cohort included men + women.
a Egan et al. (2007) (women: 60–65 years).
b Larsen et al. (2002) (men + women).
c National Food Institute (2013) (men + women).
d Järup et al. (1998) (men + women).
e Watanabe et al. (2000) (women).
f Ikeda et al. (1999) (women).
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Table 3
Data summary from studies on dietary cadmium intake and postmenopausal women breast cancer.
References Geographic location Exposure N. of cases
(/controls)
Estimator of
relative risk
Risk estimator
data [95% CI]
Adjustment/
matching
Adams et al.
(2012)
USA (13-county area in
western Washington State)
[VITAL cohort]
Prospective cohort
[mean μg/day (SD)]
Quartile 1 [5.8 (1.2)]
Quartile 2 [8.8 (0.7)]
Quartile 3 [11.6 (0.9)]
Quartile 4 [17.4 (4.3)]
Per μg/day
276
248
258
244
1026
HR
Reference
0.85 [0.71–1.03]
0.88 [0.72–1.08]
0.84 [0.67–1.06]
0.99 [0.97–1.01]
Age and total energy intake
Quartile 1
Quartile 2
Quartile 3
Quartile 4
Per μg/day
[range: 0.5–55.7 μg/day; mean: 10.9
(SD:4.9) μg/day]
232
213
230
224
899
Reference
0.91 [0.73–1.15]
1.03 [0.79–1.35]
1.00 [0.72–1.41]
1.00 [0.98–1.02]
Age, total energy intake, education, race,
HRT use, vegetable consumption
(excluding potatoes), potato consumption,
whole grain consumption, cigarette
smoking, BMI, physical activity, alcohol
consumption, age at ﬁrst childbirth,
multivitamin use, mammography
ER+ tumors
ER− tumors
Also stratiﬁcations for smoking, HRT,
BMI, parity, vegetable consumption,
regular multivitamin use, total zinc
intake, total iron intake, total
calcium intake
757
123
1.0 [0.98–1.03]
0.94 [0.89–1.01]
Remark: to test for the difference in
association of cadmium with ER+ and
ER− tumors, the dataset was reformulated
as a case–control study
Adams et al.
(2014)
USA (40 clinical centers)
[WHI: Women's Health
Initiative]
Prospective study
[μg/day]
Quintile 1 [b7.10]
Quintile 2 [7.10–9.24]
Quintile 3 [9.24–11.35]
Quintile 4 [11.35–14.21]
Quintile 5 [N14.21]
1198
1378
1338
1416
1328
HR
Reference
0.96 [0.89–1.04]
0.98 [0.91–1.06]
1.00 [0.93–1.08]
0.96 [0.89–1.03]
p-Trend: 0.63
Total energy intake (residual method), age
and study component (observational,
clinical trial)
Quintile 1
Quintile 2
Quintile 3
Quintile 4
Quintile 5
Reference
0.93 [0.86–1.00]
0.94 [0.87–1.02]
0.96 [0.89–1.04]
0.93 [0.86–1.00]
p-Trend: 0.20
+Body mass index, smoking, alcohol
consumption, race/ethnicity, education,
physical activity, age at ﬁrst birth, age at
menarche, age at menopause, unoppose E
use, E + PG use, mammography 2 years
prior to baseline
Quintile 1
Quintile 2
Quintile 3
Quintile 4
Quintile 5
Reference
0.92 [0.85–1.00]
0.93 [0.86–1.02]
0.94 [0.86–1.03]
0.90 [0.81–1.00]
p-Trend: 0.12
+Daily vegetables serving, daily grain
servings
Eriksen et al.
(2014)
Denmark;
[Diet, Cancer and Health
cohort]Prospective cohort
study
[μg/day]
Tertile 1 [b11.9]
Tertile 2 [11.9–15.3]
Tertile 3 [N15.3]
Per 10 μg Cd/day
468
461
461
1390
IRR
Reference
0.96 [0.85–1.10]
0.97 [0.85–1.11]
0.99 [0.87–1.13]
Age is underlying time-scale. Adjusted for
educational level, smoking status, number
of births, age at ﬁrst birth, HRT status, HRT
use, age at menarche, BMI, height, physical
activity and alcohol intake.
Per 10 μg Cd/day
ER+ tumors
ER− tumors
Also stratiﬁcations for PGR,
histology, education, smoking, HRT,
BMI, total zinc intake, total iron
intake
981
228
1.0 [0.85–1.15]
0.88 [0.62–1.22]
Itoh et al.
(2014)
Japan (4 hospitals in Naga-
no Prefecture)
Case–control study
[Median intake: μg/day]
Low tertile [21.4]
Middle tertile [26.2]
High tertile [31.5]
Continuous intake
ER+ tumors
Low tertile [21.4]
Middle tertile [26.2]
High tertile [31.5]
Continuous intake
ER− tumors
Low tertile [21.4]
Middle tertile [26.2]
High tertile [31.5]
Continuous intake
Also stratiﬁcations for PGR status
68/70
66/89
78/94
43
48
65
25
17
12
OR
OR
1.00
1.01 [0.60–1.71]
1.49 [0.84–2.64]
p-Trend: 0.16
1.06 [1.01–1.11]
1.00
1.16 [0.65–2.07]
1.94 [1.04–3.63]
p-Trend: 0.032*
1.08 [1.03–1.14]
1.00
0.69 [0.32–1.48]
0.62 [0.25–1.51]
p-Trend: 0.28
0.99 [0.92–1.06]
Age, residential area, moderate physical
activity in the past 5 years, smoking status,
family history for breast cancer, number of
births, isoﬂavone intake, vegetable intake,
total energy intake
(continued on next page)
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Table 3 (continued)
References Geographic location Exposure N. of cases
(/controls)
Estimator of
relative risk
Risk estimator
data [95% CI]
Adjustment/
matching
Julin et al.
(2012)
Sweden central counties:
Västmanland and Uppsala
[Swedish Mammography
Cohort]
Prospective cohort
[intake: μg/day] (median)
Low tertile [b13 (12)]
Middle tertile [13–16 (15)]
High tertile [N16 (17)]
677
691
744
RR (highest
tertile/lower) 1.00
1.00 [0.90–1.11]
1.06 [0.95–1.17]
p-Trend: 0.25
Age
Low tertile [b13 (12)]
Middle tertile [13–16 (15)]
High tertile [N16 (17)]
677
691
744
1.00
1.00 [0.90–1.11]
1.05 [0.95–1.17]
p-Trend: 0.26
Age, adult height, BMI, N12 years of
education, use of oral contraceptives, use
of postmenopausal hormones, age at
menarche, age at menopause, parity, age at
ﬁrst birth, alcohol consumption, glycemic
load, total energy intake.
Low tertile [b13 (12)]
Middle tertile [13–16 (15)]
High tertile [N16 (17)]
677
691
744
1.00
1.06 [0.95–1.18]
1.21 [1.07–1.36]
p-Trend: 0.02⁎
(p b 0.05)
+Intake of whole grain and vegetables in
tertiles
ER+ tumors
Low tertile [b13 (12)]
Middle tertile [13–16 (15)]
High tertile [N16 (17)]
538
520
568
1.00
1.01 [0.89–1.15]
1.19 [1.03–1.36]
p-Trend: 0.02⁎
Age, adult height, BMI, N12 years of
education, use of oral contraceptives, use
of postmenopausal hormones, age at
menarche, age at menopause, parity, age at
ﬁrst birth, alcohol consumption, glycemic
load, total energy intake + intake of whole
grain and vegetables in tertiles
ER− tumors
Low tertile [b13 (12)]
Middle tertile [13–16 (15)]
High tertile [N16 (17)]
Also data only for lean and normal
weight postmenopausal women
83
101
106
1.00
1.22 [0.90–1.66]
1.33 [0.95–1.87]
p-Trend: 0.60
Sawada et al.
(2012)
Japan (2 cohorts — I: 5
public health center areas
(Iwate, Akita, Nagano,
Okinawa, Tokyo excluded in
the present study); II: 6
areas (Ibaraki, Niigata,
Kochi, Nagasaki, Okinawa,
Osaka))
[The Japan Public Health
Center-based Prospective
Study]
Prospective cohort
[Median intake: μg/day]
Low tertile [19.2]
Middle tertile [24.9]
High tertile [32.3]
? b 124
? b 141
? b 137
HR (highest
vs lowest
cadmium
intake
group)
1.00
1.35 [0.95–1.90]
0.95 [0.62–1.46]
Age, area, BMI, smoking status, frequency
of alcohol intake, leisure-time physical
activity, intake of meat, soybean,
vegetable, fruit, menopausal status, use of
exogenous female hormones
Remark: risk estimator data was for
postmenopausal women only but reported
numbers of cases are for pre- +
postmenopausal women [percentage of
postmenopausal women = from 75 to
82%].
Abbreviations: BMI, bodymass index; CI, conﬁdence interval; E, estrogen; ER+or ER−, estrogen receptor status; HR, hazard ratio; HRT, hormone replacement therapy; IRR, incidence rate
ratio; OR, odds ratio; PG, progesterone; PGR, progesterone receptor status; RR, rate ratio; and SD, standard deviation.
Bold data indicates signiﬁcant at risk estimators when the 95% CI do not include 1.
⁎ statistically signiﬁcant.
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geneity were calculated as proposed by Higgins and Thompson
(2002).
2.3.2. Statistical pooling
When there was little variation between studies (I2 ≤ 25%; Higgins
et al., 2003), we calculated RRs and CIs according to a ﬁxed model
which assumes that results across studies differ only by sampling
error. The study variance (Vi) was calculated, using the CI given, accord-
ing to the equation Vi = [(ln(CIupper)− ln(CIlower)) / 3.92]2. As detailed
by Stewart et al. (1999) andDennis (2000), themaximum likelihood es-
timate of the pooled RR in the ﬁxed effect model is the exp(ln(RR)p).
The pooled ln(RR)p equals Σ[ln(RR)i / Vi] / [Σ(1 / Vi)], where Vi is the
variance for an individual study as described above and ln(RR)i is the
log RR estimate for study i. This is a variance-weighted least square
mean. The variance of the pooled ln(RR)p, Var(ln(RR)p) or Vp is given
by: [SE(ln(RR)p)]2 = [Σ(1 / Vi)]−1 where SE is the standard error. The
pooled variance is used to calculate a 95% CI around the pooled RR
estimate.
When data are heterogeneous (I2 N 25%) or if there is reason to be-
lieve that publication bias exists, the random effects model is more ap-
propriate. Under this model, the point estimate of the pooled effect
measure and its CI incorporate the additional variability due to
between-study variance (τ2). Random effects models were applied,using themethod described by DerSimonian and Laird (1986)who pro-
posed a non-iterative estimator of τ2 deﬁned as est(τ2) =max{0, [Q−
(k− 1)] / [Σwi− (Σ(wi2)) /Σwi}whereQ is theheterogeneity statistic, k
is the total number of studies, and wi are the inverse variance weights
for ln(RR). Potential sources of heterogeneity were evaluated by subset
analyses.
The meta-analysis including all studies for dietary Cd intake and
postmenopausal women breast cancer is illustrated by a forest plot
where the conﬁdence interval for each study is represented by a
horizontal line and the point estimate by a square. The size of the
square corresponds to the weight of the study in the meta-
analysis. The conﬁdence interval for the total is symbolized by a
diamond.2.3.3. Publication bias
Potential publication bias due to study size (tendency for the smaller
studies to show larger effects) was explored by plotting the natural log-
arithm of the estimate of RR (ln RR) versus the inverse of standard error
(1/SE). Funnel plot asymmetry was tested using the linear regression
method suggested by Egger et al. (1997).
Other selection biases (like language bias) and other factors such as
differences in study quality or study heterogeneity may also produce
asymmetry in funnel plots (Rothstein et al., 2005).
Table 4
Dietary cadmium exposure and risk of postmenopausal breast cancer: meta-analyses after stratiﬁcation of the studies.
Stratiﬁcations N. studies Meta-RR [95% CI] χ2 Woolf p-Value I2 (%) 95% UI
All studies (1) 6 1.03 [0.89–1.19] 15.521 0.836 × 10−2 68 24–86
Study design
Cohort (2) 5 1.01 [0.88–1.16] 13.752 0.813 × 10−2 71 26–89
Case–control (3) 1 / / / / / /
ER status
ER+ (4) 4 1.08 [0.95–1.22] 10.08 0.018 70 15–90
ER− (5) 4 0.98 [0.81–1.17] 4.951 0.175 39 0–79
PGR status
PGR+ (6) 2 1.04 [0.60–1.80] 2.501 0.114 60 0–91
PGR− (7) 2 1.15 [0.88–1.49] 0.163 0.686 0 ND
Smoking status
Never (8) 2 1.01 [0.98–1.04] 0.909 0.340 0 ND
Ever (9) 2 0.99 [0.96–1.01] 0.136 0.712 0 ND
HRT use
Never (10) 2 0.99 [0.97–1.02] 0.009 0.924 0 ND
Ever (11) 2 1.00 [0.97–1.02] 0.295 0.587 0 ND
BMI
b25 kg/m2 (12) 2 1.01 [0.99–1.04] 0.580 0.446 0 ND
≥25 kg/m2 (13) 2 0.98 [0.92–1.04] 1.171 0.279 0 ND
Zinc°
Low (14) 2 1.02 [0.98–1.06] 0.032 0.858 0 ND
High (15) 2 1.00 [0.98–1.02] 0.054 0.817 0 ND
Iron°
Low (16) 2 1.00 [0.95–1.06] 0.000 / / ND
High (17) 2 1.00 [0.98–1.02] 0.014 0.906 0 ND
Geographic location
Europe 2 1.09 [0.87–1.35] 5.834 0.0157 82 28–96
USA 2 0.91 [0.82–1.00] 0.344 0.558 0 ND
Japan 2 1.14 [0.74–1.76] 1.522 0.217 34 ND
Sensitivity study
All studies less Adams et al. (2012)⁎ (18) 5 1.04 [0.88–1.21] 15.515 0.374 × 10−2 74 36–90
All studies less Itoh et al. (2014)⁎⁎ (19) 5 1.01 [0.88–1.16] 13.752 0.813 × 10−2 71 26–89
All studies less Adams et al. (2012)⁎ and Itoh et al. (2014)⁎⁎ (20) 4 1.01 [0.86–1.19] 13.750 0.327 × 10−2 78 41–92
Abbreviations: N. studies, number of studies; meta-RR, meta-rate ratio; 95% CI, 95% conﬁdence interval; 95% UI, 95% uncertainty interval; and ND, not deﬁned (could not be calculated).
Notes: where studies reported results for tertiles/quartiles/quintiles, the data for the highest were used.Where resultswere reported for several levels of adjustment, the data adjusted for
the larger number of parameters was used.
Included studies were:
(1): Adams et al. (2012), Adams et al. (2014), Eriksen et al. (2014), Itoh et al. (2014), Julin et al. (2012), and Sawada et al. (2012).
(2): Adams et al. (2012), Adams et al. (2014), Eriksen et al. (2014), Julin et al. (2012), and Sawada et al. (2012).
(3): Itoh et al. (2014).
(4): Adams et al. (2012), Eriksen et al. (2014), Itoh et al. (2014), and Julin et al. (2012).
(5): Adams et al. (2012), Eriksen et al. (2014), Itoh et al. (2014), and Julin et al. (2012).
(6): Eriksen et al. (2014) and Itoh et al. (2014).
(7): Eriksen et al. (2014) and Itoh et al. (2014).
(8) to (17): Adams et al. (2012) and Eriksen et al. (2014).
(18): Adams et al. (2014), Eriksen et al. (2014), Itoh et al. (2014), Julin et al. (2012), and Sawada et al. (2012).
(19): Adams et al. (2012), Adams et al. (2014), Eriksen et al. (2014), Julin et al. (2012), and Sawada et al. (2012).
(20): Adams et al. (2014), Eriksen et al. (2014), Julin et al. (2012), and Sawada et al. (2012).
° Total intake from diet and supplement and multivitamins, cut-offs correspond to lowest quartile among all participants (Adams et al., 2012) or to the median (Eriksen et al., 2014).
⁎ Adams et al. (2014) study participantswere from40 clinical centers across theUSA, one center being located in Seattle (WesternWashington state) and theparticipants of the studyof
Adams et al. (2012) were from 13-county areas inWesternWashington state. As redundancy between some data from Adams et al. (2012) and Adams et al. (2014) cannot be excluded,
sensitivity analysis was performed excluding the study of Adams et al. (2012).
⁎⁎ The participants of the study of Sawada et al. (2012) were from 9 Public Health Center areas including Nagano and the Itoh's study participants are from 4 hospitals in Nagano Pre-
fecture. As redundancy between somedata from Itoh et al. (2014) and Sawada et al. (2012) cannot be excluded, sensitivity analysiswas performed excluding the studyof Itoh et al. (2014).
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To determine the robustness of the ﬁndings as well as to determine
whether some of the decisionsmade had amajor effect on the results of
the review, sensitivity analyses were conducted. The meta-analysis of
all studies was performed using both ﬁxed and random effect methods.
When redundancy between some data from different studies could not
be totally excluded, sensitivity analysis was performed by excluding the
smaller studies.
3. Results
3.1. Literature selection and study characteristics
The study selection process is summarized in the ﬂow chart in Fig. 1.
A total of 129 articleswere retrieved fromMEDLINE and hand searchingin the reference lists of the relevant publications. Among these studies,
123 were excluded as they did not fulﬁll the inclusion criteria because
they were non-English articles (n = 4), non-human studies (n = 21),
or because they were reviews and/or meta-analyses (n = 22), mecha-
nistic and genetic studies (n = 18), studies unrelated to cancer and
breast cancer (n= 51), unrelated to dietary exposure (n= 3), unrelat-
ed to Cd (n = 1) or unrelated to postmenopausal women (n = 3).
The 6 remaining studies were included in present analyses. Five co-
hort studies (Adams et al., 2012; Adams et al., 2014; Eriksen et al., 2014;
Julin et al., 2012; Sawada et al., 2012) and one case–control study (Itoh
et al., 2014) were identiﬁed as fulﬁlling the inclusion criteria.
Table 1 provides selected characteristics of the studies included in
the analysis. They were published between 2012 and 2014. The case–
control study and 1 cohort study were from Japan, 2 cohort studies
were from North America and 2 cohort studies from Europe.
10 G. Van Maele-Fabry et al. / Environment International 86 (2016) 1–13Themean estimated Cd intake in the cohorts were between 10.9 and
15 μg/day in the European and North American cohorts and of 26.4 and
26.5 μg/day for the Japanese studies (Table 2).
Dietary intakes were assessed in all studies by using a self-
administered food frequency questionnaire (FFQ) including between
67 and 192 items. Exposure categories were presented as tertiles, quar-
tiles and quintiles. Case numbers and estimators of the relative risk
(along with their CIs) for postmenopausal women to develop breast
cancer after exposure to Cd were extracted from individual studies
and presented in Table 3 according to the exposure. Estimators of rela-
tive risk used by the primary authors included rate ratio (RR), hazard
ratio (HR), odds ratio (OR), incidence rate ratio (IRR).
3.2. Data synthesis
3.2.1. Meta-analyses
Table 4 summarizes the results of the different meta-analyses per-
formed. The meta-rate ratio calculated according to the random effect
model was 1.03 (95% CI: 0.89–1.19) for all included studies. A forest
plot of the 6 studies is reported on Fig. 2.
The meta-rate ratio revealed a slight non-statistically signiﬁcant in-
creased risk of breast cancer among postmenopausal women exposed
to Cd through the diet. However, the high heterogeneity and degree of
inconsistency among the 6 relative risk estimates (p value of
0.836 × 10−2 and I2 of 68%) argued against an overall meta-analysis of
the data. Further analyses were therefore carried out to identify the
sources of heterogeneity, stratifying studies according to different vari-
ables including tumor ER status, PGR status, smoking status, HRT use,
BMI, zinc intake, iron intake and geographic location. No signiﬁcant pos-
itive association betweendietary Cd exposure and breast cancer in post-
menopausal women was found in any subgroup.
Stratiﬁcation by study design did not reveal inconsistency among
studies with a cohort design.
No statistically increased risk of breast cancer was found after strat-
iﬁcation by estrogen receptor status (ER+ or ER−). Less inconsistency/
heterogeneity between study results was observed when combining
data from the four studies reporting on ER− tumors (p value of 0.175
and I2 of 39%) than when combining data from the four studies
reporting on ER+ tumors (p value of 0.0179 and I2 of 70%). Stratiﬁca-
tion according to the PGR status resulted in consistency among studies
for PGR− (I2 = 0; n = 2 only) but not for PGR+ as well as for
Japanese and American studies but not for the European studies. Het-
erogeneity and inconsistency were drastically reduced after stratiﬁca-
tion for smoking status, HRT use, BMI status, zinc and iron intake but
only 2 studies were available for each subgroup.
3.2.2. Sensitivity analyses
The meta-analysis performed on all studies using ﬁxed or random
effects models yielded very similar results (ﬁxed model, mRR: 1.01,
95% CI: 0.95–1.08; random model, mRR: 1.03, 95% CI: 0.89–1.19).
Omitting studies with potentially redundant data (Adams et al.,
2012 and Itoh et al. 2014) did not substantially modify the results
(n = 4) (mRR: 1.01; 95% CI: 0.86–1.19) (Table 4).
3.2.3. Funnel plots and asymmetry
Funnel plot of ln(RR) versus 1/SE for the meta-analysis including all
studies was constructed (Fig. 3). The visual inspection of this ﬁgure did
not clearly allow detecting asymmetry arising from a lack of small stud-
ies with low RR estimators. The statistical analysis provided by the line-
ar regression method of Egger et al. (1997) did not yield evidence of
asymmetry (intercept: 0.787; 95% CI:−3.873 to 5.448) (p N 0.20).
4. Discussion
Only few studies linking dietary Cd exposure to breast cancer risk are
available. Two meta-analyses were performed on data from studiesincluding women irrespective of their hormonal status (Cho et al.,
2013; Wu et al., 2015). In a subgroup analysis of their updated meta-
analysis, Wu et al. (2015) combined data from 4 studies concerning
postmenopausal women. The present study is, to our knowledge, the
ﬁrst comprehensive meta-analysis focusing exclusively on postmeno-
pausal women and combining data from 6 studies on dietary Cd expo-
sure and breast cancer risk.
The overall results from this meta-analysis do not suggest evidence
of an association between dietary exposure to Cd and breast cancer in
postmenopausal women. The risk was not statistically signiﬁcant and
did not vary substantiallywhen using theﬁxedmodel orwhen omitting
studies with potential redundancy. However, the strong heterogeneity
and degree of inconsistency existing among the 6 individual risk esti-
mates argues against conducting an overall meta-analysis, and the in-
terpretation must be done with caution. Several differences among
individual studies that may account for this heterogeneity were ana-
lyzed, including study design, geographic location or ethnicity, breast
cancer type, inﬂuence of other risk factors for breast cancer like smoking
status, high BMI andHRT or elements interactingwith the absorption of
Cd (zinc, iron).
Grouping of the studies by geographic location strongly reduced het-
erogeneity among Japanese studies and evidence of heterogeneity was
nomore observed among American studies. The main source of hetero-
geneity comes from the European studies. This was already observed in
the meta-analysis of Wu et al. (2015) including pre- and postmeno-
pausal women and heterogeneity was explained by the differences in
adjustment factors considered in the two European studies. In a meta-
analysis on breast cancer (all women) and exposure (from all sources)
to Cd estimated by using different sampling methods (including hair,
urine, tissue and peripheral venous blood), higher frequencies of breast
cancer were observed among Cd exposed Asians comparedwith Cauca-
sian population (Rahim et al., 2013). We investigated if heterogeneity
could be due to ethnicity differences by combining studies with Cauca-
sian populations (USA and European) but heterogeneity was not re-
duced (meta-RR: 1.02; 95% CI: 0.87–1.19; I2: 78%).
Although breast cancers constitute a heterogeneous group of neo-
plasms, most epidemiologic research to date has viewed breast cancer
as a single disease with the risk of diluting or masking associations for
a speciﬁc form of breast cancer. Breast cancers can be classiﬁed accord-
ing to the expression of estrogen receptor (ER) and/or progesterone re-
ceptor (PGR) that have different clinical, pathologic, and molecular
features, and it has been suggested that breast cancers stratiﬁed by hor-
mone receptor status are also etiologically distinct diseases (Althuis
et al., 2004). Assessing risk factors for breast cancers stratiﬁed by path-
ologic features has raised increasing interest and showed, as an exam-
ple, that reproduction-related exposures (risk factors for breast
cancer) tended to be associated with increased risk of ER-positive but
not ER-negative tumors. ER status was reported in 4 studies included
in our meta-analysis and an elective impact of Cd exposure did not ap-
pear in ER+ tumors. After stratiﬁcation of the two studies reporting
tumor PGR status, no evidence of heterogeneity remained for PGR−
grouping although high heterogeneity was observed for PGR+. A simi-
lar pattern of lack of evidencewas observed in all other groups analyzed
and stratiﬁed for risk factors including smoking status, HRT use and BMI.
The combined risk estimates were close to 1, none of them being statis-
tically signiﬁcant.
The accumulation of Cd in tissues and organs of environmentally ex-
posed individuals results most probably from the efﬁcient absorption
and systemic transport of Cd, by mechanisms developed for essential
metals, most likely to be zinc (Zn2+), iron (Fe2+), manganese
(Mn2+), and calcium (Ca2+) (Satarug et al., 2010). There is somemech-
anistic evidence that Cd competes with these metals and calcium for
binding sites on cellular proteins (metallothionein) (Klaassen et al.,
1999, 2009). One would expect that the association between dietary
Cd intake and breast cancer would be the strongest among women
with low levels of zinc, iron or calcium intake. Comparing studies that
Fig. 2. Forest plot of studies on dietary exposure to cadmium and breast cancer in postmenopausalwomen (randomeffectmodel). Note. Estimators of RR and95% conﬁdence intervals (CI)
of studies included in the meta-analysis “all studies” are presented. Each estimator was assigned a weight (wi) equal to the inverse square of its standard error (SE): wi = 1 / (SE)2.
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ences. No evidence of heterogeneity was observed whatever the
subgroup.
It has, however, to be stressed that the lownumber of studies includ-
ed in the stratiﬁcations led to restricted statistical power and less pre-
cise risk estimates in some analyses.
One strength of our study is that it focuses on postmenopausal
women. This study population is the most appropriate to investigate
the possible impact of exogenous factors with estrogenic activity, like
Cd, on breast cancer as, after menopause, exogenous estrogens are pre-
dominant. Restricting the analysis to postmenopausal women limits the
impact of endogenous estrogens (produced by the ovaries) potentially
unmasking the possible estrogenic inﬂuence of Cd (Strumylaite et al.,
2010). Another strength of ourmeta-analysis is that 5 out of the 6 avail-
able studies have a prospective cohort design which reduced the recall
and selection bias. Publication bias is a serious concern in meta-
analysis that can be detected by funnel plot asymmetry. We found no
evidence of publication bias. All included studies are recent (2012–
2014) and properly conducted. For each study, estimated Cd intake is
in great agreement with the mean intake reported for the general pop-
ulation of the respective countries (Table 2). Furthermore, several fac-
tors that may have inﬂuenced the effect of dietary Cd exposure on the
development of breast cancer have been investigated, including study
design, geographic location or ethnicity, breast cancer type, smoker sta-
tus, high BMI, HRT, zinc and iron.
Themajor limitation of all included studies is the non-ability of accu-
rately assessing individual dietary Cd intake. All these studies assessed
Cd dietary intake by combining FFQ responses with national data on
food Cd content. Misclassiﬁcation of estimated dietary Cd may have
been introduced from multiple sources including social desirability
bias and poor recall bias. FFQ responses may not reﬂect long term die-
tary patterns of exposure as FFQ asked about diet in short periods
prior to enrollment (3 months, 1 year). In addition, as reported by
Adams et al. (2012), Cd content in food items is subject to variations
as the amount of Cd absorbed by plants depends on growing location,Fig. 3. Funnel plot of all studies on dietary exposure to cadmium and breast cancer in post-
menopausal women. Note. Funnel plot of logarithms of relative risk (RR) estimates vs the
inverse of their standard errors (1/SE) (ln of the 6 studies combined = 0.0291).agricultural conditions as well as crop varietals (Arao and Ae, 2003;
Peralta-Videa et al., 2009). Overall, measurement error in assessing of
dietary Cd would be non-differential in these prospective studies and
could have introduced substantial bias towards a ﬁnding of no associa-
tion (Freedman et al., 2011). As a consequence, whether the no in-
creased risk reﬂects a true lack of association with breast cancer or
whether the results reﬂect non-differential exposure measurement
error in the estimation of dietary Cd intake concealing a true association
remains unclear. Cadmium in urine reﬂects the body burden and is be-
lieved to be an objective indicator for the cumulative long term expo-
sure (Lauwerys et al., 1994). Three case–control studies (McElroy
et al., 2006; Gallagher et al., 2010;Wei et al., 2015) and one prospective
mortality cohort study (García-Esquinas et al., 2014) reported data on
the association between urinary Cd and breast cancer among women
populations includingmore than 85% postmenopausal women. One ret-
rospective case–control study showed signiﬁcant increased risk of
breast cancer among one of their two studied populations (Gallagher
et al., 2010). However, as in this study urinary Cd concentration was
measured after cancer diagnosis, it has been suggested by Adams et al.
(2012, 2014) that cancer treatment and changes in lifestyles due to dis-
ease status may have inﬂuenced Cd excretion. Non-signiﬁcant risks
were observed for the second population studied by Gallagher as well
as in the two others case–control studies (McElroy et al., 2006; Wei
et al., 2015). Non-signiﬁcantly decreased risk was reported in the pro-
spective mortality study (García-Esquinas et al., 2014). Apparent dis-
crepancies among the results of these studies need further
explorations. Amore valid assessment of Cd exposure would be a direct
measure of Cd body burden (provided by urine Cd concentration) at en-
rollment, before cancer diagnosis as it has be done byWei et al. (2015).
Another limitation, also underlined by Julin et al. (2012) and com-
mon to all studies included in our meta-analysis, is that they could be
subject to unmeasured confounding. Furthermore, all included studies
were conducted in developed countries and in spite of the fact that
they are relatively similar in exposure assessment and in study design,
they represent countries with differences in dietary habits, quality of
Cd monitoring data, Cd pollution levels which could have impacted
these studies differently. Notably, when compared internationally, the
dietary Cd intake in Japan is higher than in other countries (Table 2)
but no signiﬁcantly increased risk was observed in this population.
5. Conclusion
We did not detect a statistically signiﬁcant increased risk of breast
cancer among postmenopausal women related to dietary Cd intake.
Subgroup analyses allowed identifying several sources of inconsistency
between studies including geographical location, tumor ER, PGR and
smoker status, HRT use, BMI, zinc and iron absorption. As studies esti-
mating the dietary Cd intake in relation to breast cancer have only
been performed during the last few years, the number of available stud-
ies is limited and stratiﬁcations led to restricted statistical power and
less precise risk estimates. The concern for an increased risk of breast
12 G. Van Maele-Fabry et al. / Environment International 86 (2016) 1–13cancer caused by the estrogenic activity of Cd needs further investiga-
tionswith a focus on improved accuracy of individual dietary Cd intakes
and differentiation of breast cancers by pathologic features.
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